ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1310

Osteoarthritis: What’s in a Name?

Warren A Katz1, 1Penn Medicine; University of Pennsylvania School of Medicine, Upper Gwynedd, PA

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: arthritis management and inflammation, history, Osteoarthritis, osteoarthrosis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: Osteoarthritis – Clinical Poster I

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: The nomenclature of “osteoarthritis” (OA) has been a source of confusion and likely misdiagnosis for centuries.  Prior to 1759, most patients with joint diseases were labeled as having gout.  It was then that the physician-anatomist, John Hunter, first documented the gross pathology of cartilage deterioration that would eventually be called OA. Other pundits variously referred to it by many different names. The goal of this research was to analyze the chronology and rationale for naming the conventional predecessors of OA.

Methods: Google Scholar (GS), a search engine that indexes the text of academic literature, measured the usage of the terms: OA, osteo-arthritis (O-A), arthritis deformans (AD), hypertrophic arthritis (HA), degenerative joint disease (DJD) and osteoarthrosis. The terminology prevalence was plotted on a graph for each decade after 1800 to create a timeline. The Google Ngram Viewer (GNV), an online search engine that charts printed word citations, enabled a comparative graphic display between the years 1500 and 2008. A comprehensive literature search of significant discoveries and insights during this period was performed to determine if there was associated joint inflammation.

Results: The peak use of “gout” between ~1760 and 1840 may have reflected an age of scientific enlightenment rather than true prevalence. A century after Hunter’s discovery, Rudolf Virchow’s introduction of AD in 1863 applied to a mix of now-recognized OA and RA. This confounding designation persisted in the literature, eventually being adopted by his student, Sir William Osler, in 1892 and Ralph Pemberton as late as 1929. Richard von Volkmann is often credited for first using hyphenated O-A for the degenerative process, but a computerized search of his 1865 writings failed to reveal any mention of the term. In 1869, O-A originally appeared in The Nomenclature of Diseases published by the Royal College of Physicians of London. The report, though it conflated O-A with RA, gained some traction with increased usage of O-A by the mid-1860s. In 1890, the influential physician Archibald Garrod still listed both O-A and AD as clinical varieties of RA.    In 1910, he completely reversed his position by announcing: “I am convinced that the malady called ‘osteo-arthritis’… is wholly distinct from those already referred to…,” thus using O-A as a recognizable separate entity for the first time in the medical literature.   In that same year, Joel Goldthwait and his group introduced with regularity the unhyphenated form of OA.  Despite these clarifications, AD, DJD and HA continued to prevail. “Osteoarthrosis” was prevalent, mainly in the British literature, from ~1960 to 2000 because of the inference that OA was noninflammatory.  By 1950, the term OA gained rising popularity and now reflects an inherent scientifically proven inflammatory component.

Conclusion: In the history of humanity, OA has been appropriately titled for only ~100 years. Reviewers of pre-20th century literature cannot be confident that O-A, as described then, was the actual disease known today. Optimistically, the validity of “itis” as a suffix in OA indicating inflammation will translate to improved management.


ACR Image 1 Google Ngram Viewer Gout 5-31-19

Google Ngram Viewer – Gout


ACR Image 2 Abstract Google N-Gram.docx. 5-31-19

Google Ngram Viewer – OA, O-A, Arthritis Deformans, DJD, Hypertrophic Arthritis


ACR Image 3 OA vs Osteoarthrosis Mentions 5-31-19

Google Scholar Percentage of Literature Mentions for Osteoarthrosis & Osteoarthritis


Disclosure: W. Katz, None.

To cite this abstract in AMA style:

Katz W. Osteoarthritis: What’s in a Name? [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/osteoarthritis-whats-in-a-name/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/osteoarthritis-whats-in-a-name/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology